NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球藥瓶市場:玻璃類型(硼矽酸鹽、熔融石英)、最終用戶(製藥和生物技術公司、生物醫學研究所、醫療),到 2030 年的行業預測

Vials Market Research Report: By Glass Type (Borosilicate, Fused-Silica), End User (Pharmaceutical and Biotech Companies, Biomedical Research Organizations, Medical) - Global Industry Forecast to 2030

出版商 Prescient & Strategic Intelligence Private Limited 商品編碼 1007629
出版日期 內容資訊 英文 193 Pages
商品交期: 2-3個工作天內
價格
全球藥瓶市場:玻璃類型(硼矽酸鹽、熔融石英)、最終用戶(製藥和生物技術公司、生物醫學研究所、醫療),到 2030 年的行業預測 Vials Market Research Report: By Glass Type (Borosilicate, Fused-Silica), End User (Pharmaceutical and Biotech Companies, Biomedical Research Organizations, Medical) - Global Industry Forecast to 2030
出版日期: 2021年04月01日內容資訊: 英文 193 Pages
簡介

由於製藥行業的擴張,2020 年全球藥瓶市場規模達到 12.63 億美元。預計該市在 2021 年至 2030 年間將以 8.6% 的複合年增長率增長,到 2030 年將達到 30.47 億美元。由於慢性和急性疾病的擴散,製藥業正在蓬勃發展。

目前,COVID-19 大流行已在世界範圍內造成嚴重破壞,迄今已記錄了超過 1.51 億例病例和 300 萬例死亡。這給健康和製藥行業的感染預防和治療帶來了巨大壓力。因此,廣泛的研究與開發 (R&D) 催生了眾多藥物的開發,其中許多藥物已獲得監管機構的批准,現已在全球範圍內使用。由於這些藥物中的大多數是注射劑,大流行對藥瓶市場產生了積極影響。

本報告調查了全球藥瓶市場,包括市場規模和細分、玻璃類型的市場分析、最終用戶和地區、增長和限制因素、趨勢和機會、競爭條件以及主要公司的概況。

目錄

第 1 章調查背景

  • 調查目的
  • 市場定義
  • 按細分市場劃分的市場規模
    • 按玻璃類型劃分的市場細分
    • 按最終用戶細分市場
    • 區域市場細分
    • 分析期
    • 市場數據報告單位
      • 銷售
  • 主要利益相關者

第 2 章調查方法

  • 二次調查
  • 初步調查
    • 主要調查的受訪者細分
      • 按地區
      • 按行業進入公司
      • 按公司類型
      • 指定
  • 估計市場規模
  • 數據三角剖分
  • 匯率
  • 調查的先決條件
  • 注意事項和警告

第 3 章執行摘要

第 4 章介紹

  • 細分市場的定義
    • 按玻璃類型
      • 硼矽酸鹽
      • 熔融石英
    • 最終用戶
      • 製藥和生物技術公司
      • 生物醫學研究所
      • 醫療
      • 其他
  • 市場動態
    • 趨勢
      • 多數喜歡玻璃瓶
    • 增長因素
      • 不斷發展的製藥業
      • 提高藥瓶製造商的生產能力
      • 醫療保健費用增加
      • 增長因素對市場預測的影響分析
    • 抑制因素
      • 藥瓶成本高
      • 損壞風險
      • 抑制因素對市場預測的影響分析
    • 市場機會
      • 對疫苗包裝的需求增加
  • 波特五力分析
  • COVID-19 的影響

第 5 章全球市場規模和預測

  • 按玻璃類型
  • 最終用戶
    • 製藥和生物技術公司通過灌裝技術使用的藥瓶市場
  • 按地區

第 6 章歐洲市場規模和預測

  • 概述
  • 按玻璃類型
  • 最終用戶
    • 按灌裝技術:製藥公司和生物技術公司的藥瓶市場
  • 按國家/地區
    • 德國市場規模和預測
      • 按玻璃類型
      • 最終用戶
    • 法國市場規模和預測
      • 按玻璃類型
      • 最終用戶
    • 英國市場規模和預測
      • 按玻璃類型
      • 最終用戶
    • 意大利市場規模和預測
      • 按玻璃類型
      • 最終用戶
    • 西班牙市場規模和預測
      • 按玻璃類型
      • 最終用戶
    • 荷蘭市場規模和預測
      • 按玻璃類型
      • 最終用戶

第 7 章北美市場規模和預測

  • 概述
  • 按玻璃類型
  • 最終用戶
    • 按灌裝技術:製藥公司和生物技術公司的藥瓶市場
  • 按國家/地區
    • 美國市場規模和預測
      • 按玻璃類型
      • 最終用戶
    • 加拿大市場規模和預測
      • 按玻璃類型
      • 最終用戶

第 8 章亞太市場規模和預測

  • 概述
  • 按玻璃類型
  • 最終用戶
    • 按灌裝技術:製藥公司和生物技術公司的藥瓶市場
  • 按國家/地區
    • 日本市場規模及預測
      • 按玻璃類型
      • 最終用戶
    • 中國市場規模及預測
      • 按玻璃類型
      • 最終用戶
    • 印度市場規模及預測
      • 按玻璃類型
      • 最終用戶
    • 澳大利亞市場規模和預測
      • 按玻璃類型
      • 最終用戶

第 9 章拉丁美洲市場規模和預測

  • 概述
  • 按玻璃類型
  • 最終用戶
    • 按灌裝技術:製藥公司和生物技術公司的藥瓶市場
  • 按國家/地區
    • 巴西市場規模及預測
      • 按玻璃類型
      • 最終用戶
    • 墨西哥市場規模和預測
      • 按玻璃類型
      • 最終用戶
    • 阿根廷-非洲市場規模和預測
      • 按玻璃類型
      • 最終用戶

第 10 章中東和非洲的市場規模和預測

  • 概述
  • 按玻璃類型
  • 最終用戶
    • 按灌裝技術:製藥公司和生物技術公司的藥瓶市場
  • 按國家/地區
    • 沙特阿拉伯市場規模和預測
      • 按玻璃類型
      • 最終用戶
    • 阿拉伯聯合酋長國市場規模和預測
      • 按玻璃類型
      • 最終用戶
    • 南非市場規模及預測
      • 按玻璃類型
      • 最終用戶

第 11 章競爭形勢

  • 公司近期戰略發展
    • 擴張
    • 產品發佈
    • 合同和合作
  • 主要公司市場份額分析
  • 上市公司及其產品清單

第 12 章公司簡介

  • Phoenix Glass LLC
  • Pacific Vial Manufacturing Inc.
  • Hanna Instruments
  • PIRAMIDA d.o.o.
  • O.Berk
  • Acme Vial and Glass Company LLC
  • SGD Pharma
  • Stevanato Group
  • SCHOTT AG
  • Gerresheimer AG
  • Corning Incorporated
  • Amposan S.A.
  • TricorBraun Inc.
  • Borosil Limited
  • Piramal Glass Limited
  • Nipro Corporation
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.

第 13 章附錄

  • 縮寫
  • 來源和參考資料
  • 相關報導
目錄
Product Code: LS12177

Due to the surging incidence of chronic and acute diseases, the pharmaceutical industry is booming. As many of the drugs are administered via injection, the expanding pharma sector is expected to propel the global vials market from $1,263.0 million in 2020 to $3,047.0 million by 2030, at an 8.6% CAGR between 2021 and 2030, according to the market research report published by P&S Intelligence.

Presently, the COVID-19 pandemic is wreaking havoc on the world, with more than 151 million cases and 3 million deaths recorded thus far. This has put the healthcare and pharma sectors under immense pressure to find a cure and a way to prevent the infection. As a result, extensive research and development (R&D) has unearthed numerous drugs, many of which have already received the regulatory approval and are now being used worldwide. Since most of these drugs are injectables, the pandemic is impacting the vials market positively.

In the past, pharmaceutical and biotech companies dominated the vials market under the end user segment, and they will also witness the fastest growth in the usage of vials in the near future. As these firms manufacture drugs in bulk, they require vials in large numbers. The rising demand for more-effective drugs, owing to the increasing prevalence of chronic and acute diseases, is propelling the procurement of such products by biotech and pharma companies.

Europe is currently the most-productive vials market on account of the expansion of its pharmaceutical industry, presence of established industry players, rise in the awareness regarding the newly launched drugs, and high purchasing power of Europeans. In the years to come, the demand for vials will likely witness the fastest surge in Asia-Pacific (APAC). Key vial and pharma companies in the region are increasing their production output to meet the increasing demand for COVID vaccines.

Major players in the global vials market include Phoenix Glass LLC, Hanna Instruments, Pacific Vial Manufacturing Inc., PIRAMIDA d.o.o., Acme Vial and Glass Company LLC, O.Berk, SGD Pharma, SCHOTT AG, Stevanato Group, Gerresheimer AG, Amposan S.A., Corning Incorporated, TricorBraun Inc., Piramal Glass Limited, Borosil Limited, Nipro Corporation, Thermo Fisher Scientific Inc., and PerkinElmer Inc.

Table of Contents

Chapter 1. Research Background

  • 1.1 Research Objectives
  • 1.2 Market Definition
  • 1.3 Market Size Breakdown by Segment
    • 1.3.1 Market Segmentation by Glass Type
    • 1.3.2 Market Segmentation by End User
    • 1.3.3 Market Segmentation by Geography
    • 1.3.4 Analysis Period
    • 1.3.5 Market Data Reporting Unit
      • 1.3.5.1 Value
  • 1.4 Key Stakeholders

Chapter 2. Research Methodology

  • 2.1 Secondary Research
    • 2.1.1 Paid
    • 2.1.2 Unpaid
    • 2.1.3 P&S Intelligence Database
  • 2.2 Primary Research
    • 2.2.1 Breakdown of Primary Research Respondents
      • 2.2.1.1 By region
      • 2.2.1.2 By industry participant
      • 2.2.1.3 By company type
      • 2.2.1.4 By designation
  • 2.3 Market Size Estimation
  • 2.4 Data Triangulation
  • 2.5 Currency Conversion Rates
  • 2.6 Assumptions for the Study
  • 2.7 Notes & Caveats

Chapter 3. Executive Summary

Chapter 4. Introduction

  • 4.1 Definition of Market Segments
    • 4.1.1 By Glass Type
      • 4.1.1.1 Borosilicate
      • 4.1.1.2 Fused-silica
    • 4.1.2 By End User
      • 4.1.2.1 Pharmaceutical and biotech companies
        • 4.1.2.1.1 By filling technology
        • 4.1.2.1.1.1 Volumetric filling
        • 4.1.2.1.1.2 Liquid-level filling
      • 4.1.2.2 Biomedical research organizations
      • 4.1.2.3 Medical
      • 4.1.2.4 Others
  • 4.2 Market Dynamics
    • 4.2.1 Trends
      • 4.2.1.1 Increasing preference for glass vials
    • 4.2.2 Drivers
      • 4.2.2.1 Growing pharmaceutical industry
      • 4.2.2.2 Rising production capacity of vial manufacturers
      • 4.2.2.3 Increasing healthcare expenditure
      • 4.2.2.4 Impact analysis of drivers on market forecast
    • 4.2.3 Restraints
      • 4.2.3.1 High cost of vials
      • 4.2.3.2 High risk of breakage
      • 4.2.3.3 Impact analysis of restraints on market forecast
    • 4.2.4 Opportunities
      • 4.2.4.1 Increasing demand for vaccine packaging
  • 4.3 Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Buyers
    • 4.3.2 Bargaining Power of Suppliers
    • 4.3.3 Intensity of Rivalry
    • 4.3.4 Threat of New Entrants
    • 4.3.5 Threat of Substitutes
  • 4.4 Impact of COVID-19

Chapter 5. Global Market Size and Forecast

  • 5.1 By Glass Type
  • 5.2 By End User
    • 5.2.1 Market for Vials Used by Pharmaceutical and Biotech Companies, by Filling Technology
  • 5.3 By Region

Chapter 6. Europe Market Size and Forecast

  • 6.1 Overview
  • 6.2 By Glass Type
  • 6.3 By End User
    • 6.3.1 Market for Vials Used by Pharmaceutical and Biotech Companies, by Filling Technology
  • 6.4 By Country
    • 6.4.1 Germany Market Size and Forecast
      • 6.4.1.1 By glass type
      • 6.4.1.2 By end user
        • 6.4.1.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology
    • 6.4.2 France Market Size and Forecast
      • 6.4.2.1 By glass type
      • 6.4.2.2 By end user
        • 6.4.2.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology
    • 6.4.3 U.K. Market Size and Forecast
      • 6.4.3.1 By glass type
      • 6.4.3.2 By end user
        • 6.4.3.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology
    • 6.4.4 Italy Market Size and Forecast
      • 6.4.4.1 By glass type
      • 6.4.4.2 By end user
        • 6.4.4.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology
    • 6.4.5 Spain Market Size and Forecast
      • 6.4.5.1 By glass type
      • 6.4.5.2 By end user
        • 6.4.5.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology
    • 6.4.6 Netherlands Market Size and Forecast
      • 6.4.6.1 By glass type
      • 6.4.6.2 By end user
        • 6.4.6.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology

Chapter 7. North America Market Size and Forecast

  • 7.1 Overview
  • 7.2 By Glass Type
  • 7.3 By End User
    • 7.3.1 Market for Vials Used by Pharmaceutical and Biotech Companies, by Filling Technology
  • 7.4 By Country
    • 7.4.1 U.S. Market Size and Forecast
      • 7.4.1.1 By glass type
      • 7.4.1.2 By end user
        • 7.4.1.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology
    • 7.4.2 Canada Market Size and Forecast
      • 7.4.2.1 By glass type
      • 7.4.2.2 By end user
        • 7.4.2.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology

Chapter 8. APAC Market Size and Forecast

  • 8.1 Overview
  • 8.2 By Glass Type
  • 8.3 By End User
    • 8.3.1 Market for Vials Used by Pharmaceutical and Biotech Companies, by Filling Technology
  • 8.4 By Country
    • 8.4.1 Japan Market Size and Forecast
      • 8.4.1.1 By glass type
      • 8.4.1.2 By end user
        • 8.4.1.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology
    • 8.4.2 China Market Size and Forecast
      • 8.4.2.1 By glass type
      • 8.4.2.2 By end user
        • 8.4.2.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology
    • 8.4.3 India Market Size and Forecast
      • 8.4.3.1 By glass type
      • 8.4.3.2 By end user
        • 8.4.3.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology
    • 8.4.4 Australia Market Size and Forecast
      • 8.4.4.1 By glass type
      • 8.4.4.2 By end user
        • 8.4.4.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology

Chapter 9. LATAM Market Size and Forecast

  • 9.1 Overview
  • 9.2 By Glass Type
  • 9.3 By End User
    • 9.3.1 Market for Vials Used by Pharmaceutical and Biotech Companies, by Filling Technology
  • 9.4 By Country
    • 9.4.1 Brazil Market Size and Forecast
      • 9.4.1.1 By glass type
      • 9.4.1.2 By end user
        • 9.4.1.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology
    • 9.4.2 Mexico Market Size and Forecast
      • 9.4.2.1 By glass type
      • 9.4.2.2 By end user
        • 9.4.2.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology
    • 9.4.3 Argentina Africa Market Size and Forecast
      • 9.4.3.1 By glass type
      • 9.4.3.2 By end user
        • 9.4.3.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology

Chapter 10. MEA Market Size and Forecast

  • 10.1 Overview
  • 10.2 By Glass Type
  • 10.3 By End User
    • 10.3.1 Market for Vials Used by Pharmaceutical and Biotech Companies, by Filling Technology
  • 10.4 By Country
    • 10.4.1 Saudi Arabia Market Size and Forecast
      • 10.4.1.1 By glass type
      • 10.4.1.2 By end user
        • 10.4.1.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology
    • 10.4.2 U.A.E. Market Size and Forecast
      • 10.4.2.1 By glass type
      • 10.4.2.2 By end user
        • 10.4.2.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology
    • 10.4.3 South Africa Market Size and Forecast
      • 10.4.3.1 By glass type
      • 10.4.3.2 By end user
        • 10.4.3.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology

Chapter 11. Competitive Landscape

  • 11.1 Recent Strategic Developments of Players
    • 11.1.1 Expansions
    • 11.1.2 Product Launches
    • 11.1.3 Agreements and Partnerships
  • 11.2 Market Share Analysis of Key Players
  • 11.3 List of Market Players and Their Offerings

Chapter 12. Company Profiles

  • 12.1 Phoenix Glass LLC
    • 12.1.1 Business Overview
    • 12.1.2 Product and Service Offerings
  • 12.2 Pacific Vial Manufacturing Inc.
    • 12.2.1 Business Overview
    • 12.2.2 Product and Service Offerings
  • 12.3 Hanna Instruments
    • 12.3.1 Business Overview
    • 12.3.2 Product and Service Offerings
  • 12.4 PIRAMIDA d.o.o.
    • 12.4.1 Business Overview
    • 12.4.2 Product and Service Offerings
  • 12.5 O.Berk
    • 12.5.1 Business Overview
    • 12.5.2 Product and Service Offerings
  • 12.6 Acme Vial and Glass Company LLC
    • 12.6.1 Business Overview
    • 12.6.2 Product and Service Offerings
  • 12.7 SGD Pharma
    • 12.7.1 Business Overview
    • 12.7.2 Product and Service Offerings
  • 12.8 Stevanato Group
    • 12.8.1 Business Overview
    • 12.8.2 Product and Service Offerings
  • 12.9 SCHOTT AG
    • 12.9.1 Business Overview
    • 12.9.2 Product and Service Offerings
    • 12.9.3 Key Financial Summary
  • 12.10 Gerresheimer AG
    • 12.10.1 Business Overview
    • 12.10.2 Product and Service Offerings
    • 12.10.3 Key Financial Summary
  • 12.11 Corning Incorporated
    • 12.11.1 Business Overview
    • 12.11.2 Product and Service Offerings
    • 12.11.3 Key Financial Summary
  • 12.12 Amposan S.A.
    • 12.12.1 Business Overview
    • 12.12.2 Product and Service Offerings
  • 12.13 TricorBraun Inc.
    • 12.13.1 Business Overview
    • 12.13.2 Product and Service Offerings
  • 12.14 Borosil Limited
    • 12.14.1 Business Overview
    • 12.14.2 Product and Service Offerings
    • 12.14.3 Key Financial Summary
  • 12.15 Piramal Glass Limited
    • 12.15.1 Business Overview
    • 12.15.2 Product and Service Offerings
  • 12.16 Nipro Corporation
    • 12.16.1 Business Overview
    • 12.16.2 Product and Service Offerings
    • 12.16.3 Key Financial Summary
  • 12.17 PerkinElmer Inc.
    • 12.17.1 Business Overview
    • 12.17.2 Product and Service Offerings
    • 12.17.3 Key Financial Summary
  • 12.18 Thermo Fisher Scientific Inc.
    • 12.18.1 Business Overview
    • 12.18.2 Product and Service Offerings
    • 12.18.3 Key Financial Summary

Chapter 13. Appendix

  • 13.1 Abbreviations
  • 13.2 Sources and References
  • 13.3 Related Report

LIST OF TABLES

  • TABLE 1 ANALYSIS PERIOD OF THE STUDY
  • TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 4 GLOBAL VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 5 GLOBAL VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 6 GLOBAL VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 7 GLOBAL VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 8 GLOBAL MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 9 GLOBAL MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 10 GLOBAL VIALS MARKET, BY REGION, $M (2014-2020)
  • TABLE 11 GLOBAL VIALS MARKET, BY REGION, $M (2021-2030)
  • TABLE 12 EUROPE VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 13 EUROPE VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 14 EUROPE VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 15 EUROPE VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 16 EUROPE MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 17 EUROPE MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 18 EUROPE VIALS MARKET, BY COUNTRY, $M (2014-2020)
  • TABLE 19 EUROPE VIALS MARKET, BY COUNTRY, $M (2021-2030)
  • TABLE 20 GERMANY VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 21 GERMANY VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 22 GERMANY VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 23 GERMANY VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 24 GERMANY MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 25 GERMANY MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 26 FRANCE VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 27 FRANCE VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 28 FRANCE VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 29 FRANCE VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 30 FRANCE MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 31 FRANCE MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 32 U.K. VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 33 U.K. VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 34 U.K. VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 35 U.K. VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 36 U.K. MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 37 U.K. MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 38 ITALY VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 39 ITALY VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 40 ITALY VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 41 ITALY VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 42 ITALY MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 43 ITALY MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 44 SPAIN VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 45 SPAIN VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 46 SPAIN VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 47 SPAIN VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 48 SPAIN MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 49 SPAIN MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 50 NETHERLANDS VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 51 NETHERLANDS VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 52 NETHERLANDS VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 53 NETHERLANDS VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 54 NETHERLANDS MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 55 NETHERLANDS MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 56 NORTH AMERICA VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 57 NORTH AMERICA VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 58 NORTH AMERICA VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 59 NORTH AMERICA VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 60 NORTH AMERICA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 61 NORTH AMERICA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 62 NORTH AMERICA VIALS MARKET, BY COUNTRY, $M (2014-2020)
  • TABLE 63 NORTH AMERICA VIALS MARKET, BY COUNTRY, $M (2021-2030)
  • TABLE 64 U.S. VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 65 U.S. VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 66 U.S. VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 67 U.S. VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 68 U.S. MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 69 U.S. MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 70 CANADA VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 71 CANADA VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 72 CANADA VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 73 CANADA VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 74 CANADA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 75 CANADA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 76 APAC VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 77 APAC VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 78 APAC VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 79 APAC VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 80 APAC MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 81 APAC MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 82 APAC VIALS MARKET, BY COUNTRY, $M (2014-2020)
  • TABLE 83 APAC VIALS MARKET, BY COUNTRY, $M (2021-2030)
  • TABLE 84 JAPAN VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 85 JAPAN VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 86 JAPAN VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 87 JAPAN VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 88 JAPAN MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 89 JAPAN MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 90 CHINA VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 91 CHINA VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 92 CHINA VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 93 CHINA VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 94 CHINA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 95 CHINA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 96 INDIA VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 97 INDIA VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 98 INDIA VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 99 INDIA VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 100 INDIA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 101 INDIA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 102 AUSTRALIA VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 103 AUSTRALIA VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 104 AUSTRALIA VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 105 AUSTRALIA VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 106 AUSTRALIA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 107 AUSTRALIA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 108 LATAM VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 109 LATAM VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 110 LATAM VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 111 LATAM VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 112 LATAM MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 113 LATAM MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 114 LATAM VIALS MARKET, BY COUNTRY, $M (2014-2020)
  • TABLE 115 LATAM VIALS MARKET, BY COUNTRY, $M (2021-2030)
  • TABLE 116 BRAZIL VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 117 BRAZIL VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 118 BRAZIL VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 119 BRAZIL VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 120 BRAZIL MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 121 BRAZIL MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 122 MEXICO VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 123 MEXICO VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 124 MEXICO VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 125 MEXICO VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 126 MEXICO MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 127 MEXICO MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 128 ARGENTINA VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 129 ARGENTINA VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 130 ARGENTINA VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 131 ARGENTINA VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 132 ARGENTINA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 133 ARGENTINA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 134 MEA VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 135 MEA VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 136 MEA VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 137 MEA VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 138 MEA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 139 MEA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 140 MEA VIALS MARKET, BY COUNTRY, $M (2014-2020)
  • TABLE 141 MEA VIALS MARKET, BY COUNTRY, $M (2021-2030)
  • TABLE 142 SAUDI ARABIA VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 143 SAUDI ARABIA VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 144 SAUDI ARABIA VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 145 SAUDI ARABIA VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 146 SAUDI ARABIA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 147 SAUDI ARABIA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 148 U.A.E. VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 149 U.A.E. VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 150 U.A.E. VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 151 U.A.E. VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 152 U.A.E. MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 153 U.A.E. MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 154 SOUTH AFRICA VIALS MARKET, BY GLASS TYPE, $M (2014-2020)
  • TABLE 155 SOUTH AFRICA VIALS MARKET, BY GLASS TYPE, $M (2021-2030)
  • TABLE 156 SOUTH AFRICA VIALS MARKET, BY END USER, $M (2014-2020)
  • TABLE 157 SOUTH AFRICA VIALS MARKET, BY END USER, $M (2021-2030)
  • TABLE 158 SOUTH AFRICA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014-2020)
  • TABLE 159 SOUTH AFRICA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021-2030)
  • TABLE 160 LIST OF MARKET PLAYERS AND THEIR OFFERINGS
  • TABLE 161 PHOENIX GLASS LLC - AT A GLANCE
  • TABLE 162 PACIFIC VIAL MANUFACTURING INC. - AT A GLANCE
  • TABLE 163 HANNA INSTRUMENTS - AT A GLANCE
  • TABLE 164 PIRAMIDA D.O.O. - AT A GLANCE
  • TABLE 165 O.BERK - AT A GLANCE
  • TABLE 166 ACME VIAL AND GLASS COMPANY LLC - AT A GLANCE
  • TABLE 167 SGD PHARMA - AT A GLANCE
  • TABLE 168 STEVANATO GROUP - AT A GLANCE
  • TABLE 169 SCHOTT AG - AT A GLANCE
  • TABLE 170 SCHOTT AG - KEY FINANCIAL SUMMARY
  • TABLE 171 GERRESHEIMER AG - AT A GLANCE
  • TABLE 172 GERRESHEIMER AG - KEY FINANCIAL SUMMARY
  • TABLE 173 CORNING INCORPORATED - AT A GLANCE
  • TABLE 174 CORNING INCORPORATED - KEY FINANCIAL SUMMARY
  • TABLE 175 AMPOSAN S.A. - AT A GLANCE
  • TABLE 176 TRICORBRAUN INC. - AT A GLANCE
  • TABLE 177 BOROSIL LIMITED - AT A GLANCE
  • TABLE 178 BOROSIL LIMITED - KEY FINANCIAL SUMMARY
  • TABLE 179 PIRAMAL GLASS LIMITED - AT A GLANCE
  • TABLE 180 NIPRO CORPORATION - AT A GLANCE
  • TABLE 181 NIPRO CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 182 PERKINELMER INC. - AT A GLANCE
  • TABLE 183 PERKINELMER INC. - KEY FINANCIAL SUMMARY
  • TABLE 184 THERMO FISHER SCIENTIFIC INC. - AT A GLANCE
  • TABLE 185 THERMO FISHER SCIENTIFIC INC. - KEY FINANCIAL SUMMARY

LIST OF FIGURES

  • FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT
  • FIG 2 RESEARCH METHODOLOGY
  • FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH
  • FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION
  • FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
  • FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
  • FIG 7 BREAKDOWN OF PRIMARY RESEARCH BY DESIGNATION
  • FIG 8 DATA TRIANGULATION APPROACH
  • FIG 9 CURRENCY CONVERSION RATES FOR USD (2020)
  • FIG 10 GLOBAL VIALS MARKET EXECUTIVE SUMMARY
  • FIG 11 GLOBAL HEALTHCARE EXPENDITURE PER CAPITA, $ (2015-2018)
  • FIG 12 BARGAINING POWER OF BUYERS
  • FIG 13 BARGAINING POWER OF SUPPLIERS
  • FIG 14 INTENSITY OF RIVALRY
  • FIG 15 THREAT OF NEW ENTRANTS
  • FIG 16 THREAT OF SUBSTITUTES
  • FIG 17 GLOBAL VIALS MARKET SNAPSHOT
  • FIG 18 GLOBAL VIALS MARKET, BY GLASS TYPE, $M (2014-2030)
  • FIG 19 GLOBAL VIALS MARKET, BY END USER, $M (2014-2030)
  • FIG 20 MAJOR MARKETS FOR VIALS
  • FIG 21 EUROPE VIALS MARKET, BY GLASS TYPE, $M (2014-2030)
  • FIG 22 EUROPE VIALS MARKET, BY END USER, $M (2014-2030)
  • FIG 23 EUROPE VIALS MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 24 NORTH AMERICA VIALS MARKET, BY GLASS TYPE, $M (2014-2030
  • FIG 25 NORTH AMERICA VIALS MARKET, BY END USER, $M (2014-2030)
  • FIG 26 NORTH AMERICA VIALS MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 27 APAC VIALS MARKET, BY GLASS TYPE, $M (2014-2030)
  • FIG 28 APAC VIALS MARKET, BY END USER, $M (2014-2030)
  • FIG 29 APAC VIALS MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 30 LATAM VIALS MARKET, BY GLASS TYPE, $M (2014-2030)
  • FIG 31 LATAM VIALS MARKET, BY END USER, $M (2014-2030)
  • FIG 32 LATAM VIALS MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 33 MEA VIALS MARKET, BY GLASS TYPE, $M (2014-2030)
  • FIG 34 MEA VIALS MARKET, BY END USER, $M (2014-2030)
  • FIG 35 MEA VIALS MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 36 GLOBAL VIALS MARKET SHARE OF KEY PLAYERS (2020)
  • FIG 37 SCHOTT AG - REVENUE SPLIT BY GEOGRAPHY (2020)
  • FIG 38 GERRESHEIMER AG - REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2020)
  • FIG 39 CORNING INCORPORATED - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
  • FIG 40 BOROSIL LIMITED - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
  • FIG 41 NIPRO CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
  • FIG 42 PERKINELMER INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 43 THERMO FISHER SCIENTIFIC INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)